Study guide
11.4 Urodynamic Studies: Indications, Technique & Interpretation
FEBU Part 1 Written European Board of Urology
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Strategy
1.1 FEBU Part 1 Examination Structure & Logistics 1.2 EAU Guidelines Framework & Standard Setting 1.3 Clinical Decision-Making & MCQ Strategy 1.4 Professionalism and Safe Practice
2 Chapter 2: Genitourinary Anatomy & Renal Physiology
2.1 Upper Tract Anatomy & Retroperitoneal Relationships 2.2 Lower Urinary Tract Anatomy & Neuroanatomy 2.3 Renal Physiology, Glomerular Filtration & Acid-Base Balance
3 Chapter 3: Urological Pharmacology & Diagnostic Imaging
3.1 Lower Urinary Tract Pharmacotherapy 3.2 Antimicrobial Stewardship & Perioperative Care 3.3 Diagnostic Modalities: Ultrasound, CT, mpMRI & Nuclear Medicine
4 Chapter 4: Prostate Cancer: Diagnosis & Risk Stratification
4.1 PSA Kinetics, Biomarkers & Risk Assessment 4.2 Multiparametric MRI (PI-RADS) & Biopsy Strategies 4.3 Histopathological Grading (ISUP Gleason) & Staging
5 Chapter 5: Prostate Cancer: Localized & Advanced Management
5.1 Active Surveillance & Watchful Waiting 5.2 Radical Prostatectomy & Radiation Therapy 5.3 Biochemical Recurrence & Salvage Therapies 5.4 Metastatic & Castration-Resistant Prostate Cancer (CRPC)
6 Chapter 6: Bladder Cancer: Non-Muscle Invasive (NMIBC)
6.1 TURBT Technique & Pathological Staging 6.2 EAU Risk Stratification for NMIBC 6.3 Intravesical Chemotherapy & BCG Immunotherapy
7 Chapter 7: Muscle-Invasive Bladder Cancer & Upper Tract Urothelial Carcinoma
7.1 Muscle-Invasive Bladder Cancer (MIBC) Staging & Neoadjuvant Therapy 7.2 Radical Cystectomy & Urinary Diversion 7.3 Upper Tract Urothelial Carcinoma (UTUC)
8 Chapter 8: Renal Cell Carcinoma & Adrenal Neoplasms
8.1 Histological Subtypes, Genetics & Staging of RCC 8.2 Localized RCC: Nephron-Sparing Surgery & Radical Nephrectomy 8.3 Metastatic RCC & Targeted / Immunotherapy Regimens 8.4 Adrenal Masses & Incidentalomas
9 Chapter 9: Testicular Germ Cell Tumours & Penile Cancer
9.1 Testicular Cancer Diagnosis, Staging & Tumour Markers 9.2 Management of Seminoma (Stage I to Metastatic) 9.3 Management of Non-Seminoma (Stage I to Metastatic) 9.4 Penile Cancer: Staging, Organ-Sparing & Lymphadenectomy
10 Chapter 10: Benign Prostatic Hyperplasia & Lower Urinary Tract Symptoms
10.1 BPH Pathophysiology, Natural History & Clinical Evaluation 10.2 Medical Management of Male LUTS / BPO 10.3 Interventional & Surgical Management of BPO
11 Chapter 11: Functional Urology, Incontinence & Neuro-Urology
11.1 Urinary Incontinence in Men and Women, Fistulae & Urethral Diverticula 11.2 Overactive Bladder, Bladder Pain Syndrome & Pelvic Organ Prolapse 11.3 Neurogenic Lower Urinary Tract Dysfunction (NLUTD) 11.4 Urodynamic Studies: Indications, Technique & Interpretation
12 Chapter 12: Urolithiasis: Evaluation & Medical Management
12.1 Stone Pathophysiology & Risk Factors 12.2 Metabolic Evaluation & Dietary/Medical Stone Prevention 12.3 Acute Ureteric Colic & Medical Expulsive Therapy
13 Chapter 13: Endourology & Interventional Stone Management
13.1 Shock Wave Lithotripsy (SWL) 13.2 Ureteroscopy (URS) & Retrograde Intrarenal Surgery (RIRS) 13.3 Percutaneous Nephrolithotomy (PCNL) & Endourological Safety
14 Chapter 14: Infections, Andrology & Male Infertility
14.1 Localised & Systemic UTIs, Pyelonephritis, Urosepsis & Specific Infections 14.2 Prostatitis, Epididymo-Orchitis & Fournier Gangrene 14.3 Male Infertility: Evaluation & Surgical Management 14.4 Erectile Dysfunction, Peyronie Disease, Priapism & Gender-Affirming Surgery
15 Chapter 15: Paediatric Urology, Trauma & Renal Transplantation
15.1 Cryptorchidism, Hypospadias & PUJO 15.2 Vesicoureteral Reflux, Posterior Urethral Valves & Nocturnal Enuresis 15.3 Genitourinary Trauma: Kidney, Bladder & Urethra 15.4 Renal Failure, Dialysis Indications & Renal Transplantation
11.4 Urodynamic Studies: Indications, Technique & Interpretation
Key Takeaways Explain This Topic AI
Invasive urodynamics measures intravesical (Pves) and abdominal (Pabd) pressures, deriving detrusor pressure via subtraction (Pdet = Pves - Pabd), with transducers calibrated to atmospheric pressure and leveled to the upper border of the pubic symphysis.
Compliance is ΔV/ΔPdet, measured over filling without including a detrusor contraction. Low compliance and sustained high pressures can threaten the upper tracts; neither a universal normal-compliance cutoff nor DLPP 40 cmH2O alone defines safety.
In adult men, BOOI=Pdet@Qmax−2Qmax (>40 obstructed,20–40 equivocal,<20 unobstructed) and BCI=Pdet@Qmax+5Qmax (<100 weak) aid pressure-flow interpretation. They do not independently localize obstruction or guarantee surgical outcome; male thresholds should not be applied to women.
Videourodynamics (VUDS) combines synchronized multichannel manometry and fluoroscopy, serving as the gold standard to localize the precise anatomical level of obstruction (bladder neck, external sphincter dyssynergia, urethral stricture) in complex neurogenic and non-neurogenic dysfunction.
Last updated: November 2026
11.4 Urodynamic Studies: Indications, Technique & Interpretation
Urodynamic studies (UDS) comprise a spectrum of physiological tests designed to assess the functional state of the lower urinary tract during the filling/storage and voiding/emptying phases. Adherence to the standardized definitions, measurement techniques, and quality control protocols of the International Continence Society (ICS) Good Urodynamic Practice (GUP) guidelines is essential to ensure diagnostic fidelity and prevent surgical misadventures.
1. Indications & Pre-Investigation Protocols
Urodynamic investigations are indicated when objective physiological data will alter clinical or surgical decision-making:
Clinical Indications
Incontinence : Complicated, recurrent, or mixed urinary incontinence; discordance between symptoms and physical signs; prior failed anti-incontinence surgery; or evaluation before invasive surgery in high-risk patients.
Male LUTS : Inconclusive non-invasive findings prior to invasive desobstructive surgery (e.g., Q m a x > 10 Q_{max} > 10 Q ma x > 10 mL/s with bothersome predominantly voiding symptoms, age < 50 < 50 < 50 or > 80 > 80 > 80 years, inability to void > 150 >150 > 150 mL, or previous unsuccessful invasive treatment).
Neurogenic LUTD : Baseline and follow-up assessment to characterize dysfunction and upper-tract risk, with frequency individualized to risk and neurological stability. Monitor BP and heart rate in patients at risk of AD.
Pelvic Organ Prolapse : Reduction stress testing can reveal occult SUI; use invasive urodynamics selectively when the result may change treatment.
Pre-Test Preparation
Rule Out Active UTI : Obtain urinalysis, with culture as indicated, and postpone elective invasive testing during symptomatic UTI because infection can affect results and instrumentation can cause harm.
Medication Instructions : Record current treatment and the clinical question. Give individualized instructions about continuing or temporarily withholding relevant drugs; a blanket 48–72 hour washout for all LUT medications is inappropriate, particularly for long-lasting 5-ARI effects.
2. Non-Invasive Urodynamics: Uroflowmetry & PVR
Uroflowmetry measures the volume of urine expelled through the urethra per unit time ( m L / s mL/s m L / s ). Flow (mL/s)
- ▲
- │ ╭───╮ Normal: Smooth bell-shaped curve
- │ ╭╯ ╰╮ (Qmax > 15–20 mL/s)
- │ ╭╯ ╰╮
- │ ────┴───────┴──────► Time
- │
- │ ╭───────────╮ Obstructive: Prolonged, flattened plateau
- │ ────╯ ╰──► Time (Qmax < 10 mL/s; stricture or severe BPH)
- │
- │ ╭╮ ╭╮ ╭╮ Staccato: Undulating, oscillating flow
- │ ────┴─╯╰──╯╰──╯╰───► Time (Pelvic floor spasm / DSD)
- Quality Requirements & Parameters
Volume Threshold : In adult men, a voided volume > 150 >150 > 150 mL is preferred. Repeat an unrepresentative low-volume or abnormal trace; smaller voids are not automatically invalid, and flow must be interpreted with volume and usual voiding pattern.
Key Parameters : Maximum flow rate ( Q m a x Q_{max} Q ma x ), average flow rate ( Q a v e Q_{ave} Q a v e ), voided volume ( V v o i d V_{void} V v o i d ), flow time, and time to maximum flow.
Flow Curve Morphology
Normal Bell-Shaped Curve : Rapid acceleration to a distinct peak ( Q m a x > 15 Q_{max} > 15 Q ma x > 15 mL/s in men, > 20 > 20 > 20 mL/s in women) followed by smooth deceleration.
Flattened / Plateau Curve : Prolonged, low-amplitude plateau with Q m a x < 10 Q_{max} < 10 Q ma x < 10 mL/s; suggests outlet obstruction , such as urethral stricture or BPO, but cannot by itself distinguish obstruction from detrusor weakness.
Staccato Curve : Rapid, irregular fluctuations in flow rate without reaching zero; reflects intermittent external sphincter or pelvic floor muscle contraction during voiding (dysfunctional voiding, DSD).
Interrupted / Fractionated Curve : Flow periodically drops to zero, producing multiple distinct voiding peaks; reflects abdominal straining (Valsalva voiding) in the setting of an acontractile or underactive detrusor.
Post-Void Residual (PVR)
Measured immediately following uroflowmetry via transabdominal ultrasound or in-and-out catheterization. Repeat an unexpectedly large PVR and interpret it with symptoms, voided volume, medications and upper-tract findings. There is no single universal PVR cutoff separating normal emptying from clinically significant dysfunction.
3. Invasive Filling Cystometry: Principles & Physics
Filling cystometry evaluates bladder sensation, capacity, compliance, and detrusor stability during continuous retrograde fluid filling.
Pressure Channels & Mathematical Subtraction
Two separate pressure lines are established using dual-lumen urethral and rectal balloon catheters:
Intravesical Pressure ( P v e s P_{ves} P v es ) : Total hydrostatic pressure inside the bladder, measured via a 6–8 Fr transurethral catheter.
Abdominal Pressure ( P a b d P_{abd} P ab d ) : Extravesical hydrostatic pressure, measured via a fluid-filled balloon catheter placed in the rectum (or vagina).
Subtracted Detrusor Pressure ( P d e t P_{det} P d e t ) : Pressure attributable to the bladder after removing the abdominal component, including passive filling pressure and active detrusor contraction, calculated continuously in real time via electronic subtraction: P d e t = P v e s − P a b d P_{det} = P_{ves} - P_{abd} P d e t = P v es − P ab d
With adequate pressure transmission in both channels, subtraction removes the common abdominal component during coughing, straining and position changes. Channel artefacts can still distort the result.
ICS Transducer Calibration & Leveling
External pressure transducers are zeroed to atmospheric pressure .
Mounted precisely at the anatomical reference level: the upper border of the symphysis pubis .
Initial Quality Control: The Cough Test
Before filling begins, the patient performs a brisk cough. Check that P v e s P_{ves} P v es and P a b d P_{abd} P ab d are live and show nearly equal cough responses . A brief symmetric biphasic residual on P d e t P_{det} P d e t can occur with fluid-filled lines; a sustained unbalanced response needs correction. Check throughout filling and before and after voiding.
Filling Sensations and Illustrative Adult Volumes
Choose a filling rate appropriate to the clinical question and diary. ICS estimates the maximum physiological rate as body weight (kg)/4 mL/min, commonly 20–30 mL/min. The following volumes are approximate examples, not diagnostic limits:
First Sensation of Bladder Filling : 100 to 150 mL.
First Desire to Void : 150 to 250 mL.
Strong Desire to Void : 300 to 400 mL.
Maximum Cystometric Capacity (MCC) : 400 to 600 mL.
Bladder Compliance Calculation
Bladder compliance ( C C C ) quantifies the viscoelastic ability of the detrusor and connective tissue matrix to accommodate increasing volume without generating high pressure: C = Δ V Δ P d e t C = \frac{\Delta V}{\Delta P_{det}} C = Δ P d e t Δ V
Where Δ V \Delta V Δ V is volume increment from baseline, and Δ P d e t \Delta P_{det} Δ P d e t is the change in detrusor pressure from baseline to maximum capacity (or immediately prior to an uninhibited contraction).
A value < 20 <20 < 20 mL/cmH2O is a commonly used marker of low compliance; there is no universally accepted normal cutoff.
Interpret compliance with the filling rate, absolute detrusor pressures, NDO, reflux and renal findings. Sustained high-pressure storage can damage the upper tracts; the number alone does not mandate a particular operation.
Detrusor Overactivity (DO)
Involuntary detrusor contractions during the filling phase (spontaneous or provoked by coughing, running water, or postural change).
Phasic DO : Characteristic wave-like contractions that may or may not cause urinary leakage.
Terminal DO : A single involuntary contraction occurring at cystometric capacity that cannot be suppressed, resulting in complete bladder evacuation.
4. Leak Point Pressures: DLPP vs ALPP ┌────────────────────────────────────────────────────────────────────────┐
- │ LEAK POINT PRESSURE COMPARISON │
- ├───────────────────────────────────┬────────────────────────────────────┤
- │ DETRUSOR LEAK POINT PRESSURE(DLPP)│ ABDOMINAL LEAK POINT PRESSURE(ALPP)│
- ├───────────────────────────────────┼────────────────────────────────────┤
- │ • Passive leak without contraction│ • Stress leak without contraction │
- │ • Lowest Pdet causing passive leak│ • Intravesical pressure at leak │
- │ • NO detrusor contraction / strain│ during cough or Valsalva │
- │ • No universal 40 cmH2O safety line │ • Historical<60: possible ISD │
- │ • Assess with full renal-risk data│ • Cannot grade SUI or select sling│
- └───────────────────────────────────┴────────────────────────────────────┘
- Detrusor Leak Point Pressure (DLPP)
Definition : The lowest value of subtracted detrusor pressure ( P d e t P_{det} P d e t ) at which involuntary urinary leakage occurs in the absence of a detrusor contraction or abdominal strain .
Clinical Significance : Historical studies associated higher DLPP with upper-tract deterioration, particularly in myelodysplasia. 40 cmH2O is not a universal safety boundary ; current EAU guidance considers DLPP alone insufficiently sensitive to assess upper-tract risk.
Abdominal (Valsalva) Leak Point Pressure (ALPP / VLPP)
Definition : The intravesical pressure ( P v e s P_{ves} P v es ) at which leakage occurs due to increased abdominal pressure in the absence of a detrusor contraction .
Interpretation in Stress Incontinence : Historical descriptions associate ALPP <60 cmH2O with poor sphincter function and values >90 with better closure. These are not reliable diagnostic categories for ISD or urethral hypermobility. EAU advises against using leak-point pressures to grade SUI; do not choose a sling solely from ALPP.
5. Pressure-Flow Studies (PFS) & ICS Voiding Indices
Pressure-flow studies record simultaneous P d e t P_{det} P d e t and flow rate ( Q Q Q ) throughout micturition, distinguishing bladder outlet obstruction (BOO) from detrusor underactivity (DU). ADULT MALE BOOI BOUNDARIES: Pdet@Qmax (cmH2O)
- Qmax (mL/s) Unobstructed Equivocal Obstructed
- 5 <30 30–50 >50
- 10 <40 40–60 >60
- 15 <50 50–70 >70
Boundary lines rise with flow: Pdet = 2Qmax+20 or 2Qmax+40.
They are not horizontal pressure cutoffs.
Bladder Outlet Obstruction Index (BOOI / Abrams-Griffiths Number)
Calculated in adult men to classify bladder outlet obstruction; it does not identify the anatomical site or cause: BOOI = P d e t @ Q m a x − 2 × Q m a x \text{BOOI} = P_{det@Qmax} - 2 \times Q_{max} BOOI = P d e t @ Q ma x − 2 × Q ma x
BOOI > 40 > 40 > 40 : Obstructed . High detrusor pressure driving a reduced flow rate. This supports obstruction as a contributor to symptoms and can inform counselling about deobstructive surgery; it does not guarantee success.
BOOI 20–40 : Equivocal / Indeterminate .
BOOI < 20 < 20 < 20 : Unobstructed .
Bladder Contractility Index (BCI)
An index of detrusor contraction strength used in adult men, interpreted with the full pressure-flow trace and emptying: BCI = P d e t @ Q m a x + 5 × Q m a x \text{BCI} = P_{det@Qmax} + 5 \times Q_{max} BCI = P d e t @ Q ma x + 5 × Q ma x
BCI > 150 > 150 > 150 : Strong detrusor contractility.
BCI 100–150 : Normal detrusor contractility.
BCI < 100 < 100 < 100 : Weak contraction index; consider DU using contraction duration, flow and completeness of emptying.
Note
A patient with low Q m a x Q_{max} Q ma x may have high P d e t @ Q m a x P_{det@Qmax} P d e t @ Q ma x (true mechanical obstruction) OR low P d e t @ Q m a x P_{det@Qmax} P d e t @ Q ma x (detrusor underactivity). DU without demonstrable BOO predicts less benefit from deobstructive surgery and possible persistent retention. BOO and DU can coexist; interpret the complete study and counsel individually rather than predicting certain failure from BCI alone.
6. Videourodynamics (VUDS)
Videourodynamics combines synchronized multichannel pressure-flow manometry with real-time fluoroscopy utilizing radiopaque contrast media (e.g., 15%–20% meglumine diatrizoate) as the filling infusate.
Key Clinical Indications
Complex neurogenic lower urinary tract dysfunction.
Prior failed incontinence, anti-reflux, or reconstructive surgery.
Localizing the anatomical site of bladder outlet obstruction in men < 50 < 50 < 50 years of age or women.
Anatomical Localization of Obstruction
Primary Bladder Neck Obstruction (Marion's Disease) : During a high-pressure detrusor contraction, fluoroscopy reveals a narrow, unyielding "beaked" bladder neck that fails to funnel, while the distal urethra is unobstructed.
Detrusor Sphincter Dyssynergia (DSD) : Wide opening of the bladder neck and posterior urethra terminating abruptly at a narrowed external-sphincter segment of the contrast-filled urethra during detrusor contraction.
Urethral Stricture : Persistent focal caliber narrowing in the bulbar or penile urethra with prominent pre-stenotic dilation of the posterior and proximal bulbar urethra.
Pelvic Organ Prolapse Kinking : Acute angulation and obstruction at the bladder neck or mid-urethra during straining, resolving upon manual reduction.
7. Artifacts & Quality Control Troubleshooting
Accurate interpretation mandates prompt recognition and correction of common physiological and mechanical artifacts:
Transducer Drift & Leveling Error :
Transducer placed below the symphysis pubis falsely overestimates pressures (hydrostatic water column effect); transducer placed above underestimates pressures.
Rectal Line Blockage / Fecal Occlusion :
Sign : A cough produces a sharp positive spike on P v e s P_{ves} P v es , but no deflection on P a b d P_{abd} P ab d . Subtraction generates an artifactual upward spike on P d e t P_{det} P d e t resembling a detrusor contraction.
Action : Check connections, catheter position and patency; correct or replace the catheter as needed. Flush only a suitable open/punctured measuring channel according to its instructions, never a closed rectal balloon . Repeat the cough check for nearly equal transmission.
Rectal Contraction / Spasm :
Sign : A sudden isolated rise on P a b d P_{abd} P ab d with no change in P v e s P_{ves} P v es , producing an artifactual negative deflection on the subtracted P d e t P_{det} P d e t trace.
Action : Recognize and annotate the rectal contraction and reassess after it subsides. Persistent imbalance requires troubleshooting; a small resting P d e t P_{det} P d e t around−5 to +5 cmH2O can occur in an otherwise adequate recording.
Urethral Catheter Expulsion :
Sign : Catheter slips out into the vagina or urethra during forceful voiding, causing abrupt loss of P v e s P_{ves} P v es and uncoupling of pressure-flow channels.
8. Urodynamic Indices & Reference Values Matrix
Diagnostic Parameter ICS Formula / Definition Reference Thresholds Clinical & Surgical Interpretation
Bladder Compliance ( C C C ) Δ V / Δ P d e t \Delta V / \Delta P_{det} Δ V /Δ P d e t No universal normal cutoff; < 20 <20 < 20 mL/cmH2O commonly indicates low compliance Assess sustained pressures, reflux and renal findings; treat unsafe storage and verify response
Detrusor Leak Point (DLPP) Lowest P d e t P_{det} P d e t causing passive leakage Historical 40 cmH2O risk marker, not a universal boundary DLPP alone cannot establish upper-tract safety
Abdominal Leak Point (ALPP) P v e s P_{ves} P v es causing leakage during Valsalva Historical associations with closure function Does not reliably grade SUI or determine sling route
Obstruction Index (BOOI) P d e t @ Q m a x − 2 × Q m a x P_{det@Qmax} - 2 \times Q_{max} P d e t @ Q ma x − 2 × Q ma x > 40 > 40 > 40 (Obstructed); 20 – 40 20–40 20–40 (Equivocal); < 20 < 20 < 20 (Unobstructed) Classifies obstruction in adult men; does not guarantee surgical success
Contractility Index (BCI) P d e t @ Q m a x + 5 × Q m a x P_{det@Qmax} + 5 \times Q_{max} P d e t @ Q ma x + 5 × Q ma x > 150 > 150 > 150 (Strong); 100 – 150 100–150 100–150 (Normal); < 100 < 100 < 100 (Weak) Adult-male index; integrate with contraction duration, flow, emptying and obstruction
Maximum Cystometric Capacity Volume at the end of filling; account for residual and diuresis Often around 400–600 mL, with substantial variation Interpret with diary, sensation, pain, pressure and emptying; capacity alone does not diagnose fibrosis or DU